TTK Health Care Profit & Loss Annual

BSE: 507747 | NSE: TTKHLTCARE | ISIN: INE910C01018 | Sector: Biotechnology & Drugs

1,500.00 -6.80 (-0.45%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	752.79	725.11	599.24	476.06
Total Revenue	752.79	725.11	599.24	476.06
Costof Revenue Total	338.25	350.32	287.02	211.59
Gross Profit	414.54	374.79	312.22	264.47
Selling/ General/ Admin Expenses Total	132.84	335.28	282.91	238.46
Depreciation/ Amortization	13.06	12.81	12.58	13.02
Other Operating Expenses Total	244.37	6.70	4.52	3.93
Total Operating Expense	728.53	706.43	589.97	469.64
Operating Income	24.27	18.68	9.27	6.42
Interest Inc( Exp) Net- Non- Op Total	-27.56	416.93	118.33	81.96
Other Net	62.61	1.40	1.26	0.03
Net Income Before Taxes	84.12	61.64	24.84	22.62
Provisionfor Income Taxes	21.28	16.97	6.33	-14.16
Net Income After Taxes	62.84	44.67	18.51	36.78
Net Income Before Extra Items	62.84	44.67	18.51	36.78
Total Extraordinary Items	0.00	595.05	23.08	9.66
Net Income	62.84	639.71	41.59	46.44
Income Availableto Com Excl Extra Ord	62.84	44.67	18.51	36.78
Income Availableto Com Incl Extra Ord	62.84	639.71	41.59	46.44
Diluted Net Income	62.84	639.71	41.59	46.44
Diluted Weighted Average Shares	1.41	1.41	1.41	1.41
Diluted EPS Excluding Extra Ord Items	44.47	31.61	13.10	26.03
DPS- Common Stock Primary Issue	10.00	10.00	10.00	6.00
Diluted Normalized EPS	44.47	31.68	11.79	22.36
Research Development	-	13.25	29.34	26.54
Gain( Loss)on Saleof Assets	-	-1.38	24.75	79.79